Neisseria Meningitidis Infections Pipeline Analysis 2018 – Focusing On Clinical Trials And Results, Drug Profiling, Patents, Collaborations, And Other Recent Developments
- Published : Mar 2020
- Report Code : KSI061611474
- Pages : 114
Offered with this report
Market Data and Estimates in Excel
2 Months of Post Sale Analyst Support
Requirement Specific Customization
Neisseria meningitidis Infections Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.
Neisseria meningitidis Infections Pipeline Analysis report covers drugs of 8 companies currently in different phases of development. Neisseria meningitis infections are also referred to as meningococcal disease is caused by a bacterium, Neisseria meningitidis. The disease is very serious and contagious and requires immediate medical attention. Symptoms of the disease include sudden fever, headache and stiffness of the neck. Vaccination and antibiotics are taken as preventive measures for the disease.
The report provides Neisseria meningitidis Infections treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing and out-licensing opportunities, formulating business development strategies and tracking the activities of the key market players. Epidemiology, major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Various databases (for patents and Clinical Trials), studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are Pfizer Inc, Sanofi and GlaxoSmithKline plc. among others.
Scope:
By Company
By Phase
By Molecule Type
By Region
By Route of Administration
1.1. Research Methodology
1.2. Research Scope
1.2.1. Analysis by Company
1.2.2. Analysis by Phase
1.2.3. By Molecule Type
1.2.4. By region
2. Disease Overview
2.1.1. Introduction
2.1.2. Classification
2.1.3. Symptoms
2.1.4. Causes
2.1.5. Diagnoses
2.1.6. Treatment
2.1.7. Epidemiology
3. Executive Summary
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
5. Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1. Phase of Development
5.2.1.1. Introduction
5.2.1.1.1. Drug Profiling
• Drug Name
• Generic Name
• Synonyms
• Company
• Collaborator
• Route of administration
• Target
• Mechanism of Action
• Technology
• Molecule type
• CAS Number
• Weight
• Chemical Formula
• IUPAC name
• ATC code
5.2.1.1.2. Strategic Developments
5.2.1.1.3. Clinical trials
5.2.1.1.4. Clinical trial results
5.2.1.1.5. Patents
5.2.1.1.6. Technology
5.2.2. Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region
6. Company profiling
6.1. GlaxoSmithKline plc.
6.1.1. Introduction
6.1.2. Financials
6.1.3. Products and Services
6.1.4. SWOT
6.2. Pfizer Inc.
6.2.1. Introduction
6.2.2. Financials
6.2.3. Products and Services
6.2.4. SWOT
6.3. Biological E
6.3.1. Introduction
6.3.2. Financials
6.3.3. Products and Services
6.3.4. SWOT
6.4. CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
6.4.1. Introduction
6.4.2. Financials
6.4.3. Products and Services
6.4.4. SWOT
6.5. ImmunoBiology Ltd.
6.5.1. Introduction
6.5.2. Financials
6.5.3. Products and Services
6.5.4. SWOT
6.6. Sanofi
6.6.1. Introduction
6.6.2. Financials
6.6.3. Products and Services
6.6.4. SWOT
6.7. Serum Institute of India Pvt. Ltd.
6.7.1. Introduction
6.7.2. Financials
6.7.3. Products and Services
6.7.4. SWOT
6.8. Wellstat Vaccines, LLC
6.8.1. Introduction
6.8.2. Financials
6.8.3. Products and Services
6.8.4. SWOT
List of Tables
List of Figures
Pfizer Inc.
Biological E
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
ImmunoBiology Ltd.
Sanofi
Serum Institute of India Pvt. Ltd.
Wellstat Vaccines, LLC
Related Reports
| Report Name | Published Month | Get Sample PDF |
|---|---|---|
| Stem Cell Therapy Market Size & Share: Industry Report, 2023-2028 | Oct 2023 | |
| Regenerative Stem Cell Therapies Market Size: Report, 2023 - 2028 | Oct 2023 | |
| Bone Marrow Transplant Market Size & Share: Report, 2024-2029 | Jan 2024 |